PMID: 2498073May 1, 1989Paper

Controlled trial of lamotrigine (Lamictal) for refractory partial seizures

Epilepsia
S JawadW C Yuen

Abstract

The antiepileptic effect of lamotrigine (LTG) was assessed in a double-blind, placebo-controlled crossover trial in 24 adult patients with refractory partial seizures. LTG or placebo was added to existing antiepileptic drugs (AEDs). The dose of LTG varied from 75 to 400 mg daily. Three patients did not complete the trial. One was withdrawn from the trial with ataxia, tiredness, dyspnea, and diplopia while receiving LTG and died 18 days later of invasive carcinoma involving the liver. A second patient was withdrawn during baseline for contravening admission criteria, and a third received LTG in error during both treatment periods. Twenty-one patients (12 men and 9 women) completed the trial. An analysis of seizure counts in the 12-week treatment period with LTG showed a statistically significant reduction in seizures as compared with placebo for total seizures (p less than 0.002), partial seizures (p less than 0.002), and secondarily generalized seizures (p less than 0.05). The analysis of total seizure days showed a significant reduction during LTG treatment (p less than 0.002). There were no statistically significant changes in plasma concentrations of phenytoin (PHT), carbamazepine (CBZ), primidone (PRM), or phenobarbital (PB...Continue Reading

Citations

Dec 7, 2000·Mental Retardation and Developmental Disabilities Research Reviews·J M Pellock, L D Morton
Apr 29, 1998·Journal of Clinical Pharmacology·R C SachdeoA Rosenberg
Aug 18, 1990·Lancet·M J Brodie, R J Porter
Mar 1, 1992·Seizure : the Journal of the British Epilepsy Association·T Betts
Jan 31, 2004·Epilepsy & Behavior : E&B·Edward FaughtGilda P Womble
Oct 28, 1999·International Journal of Pharmaceutics·D S AshtonK Valko
Jul 21, 2001·Epilepsy Research·M Nieto-BarreraUNKNOWN Lamictal vs. Carbamazepine Study Group
Aug 30, 2002·Epilepsy Research·Matthew D SmythScott C Baraban
Mar 1, 1995·Seizure : the Journal of the British Epilepsy Association·J P Leach, M J Brodie
Sep 1, 1994·Seizure : the Journal of the British Epilepsy Association·P J Martin, P A Millac
Mar 1, 2003·Epilepsy & Behavior : E&B·Dalma Kalogjera-Sackellares, J Chris Sackellares
Jun 7, 2003·Epilepsy & Behavior : E&B·Jorge G BurneoEdward Faught
Jun 13, 1996·The New England Journal of Medicine·M A Dichter, M J Brodie
Jul 15, 2000·Clinical Neuropharmacology·B F Bourgeois
May 1, 1992·British Journal of Clinical Pharmacology·A W YuenA W Peck
Nov 1, 1996·British Journal of Clinical Pharmacology·M G MarcianiG Bernardi
Aug 1, 1993·Journal of Clinical Pharmacy and Therapeutics·N M Graves, I E Leppik
Apr 1, 1995·Australian and New Zealand Journal of Medicine·C Kilpatrick
Jan 1, 1995·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A Sabers, L Gram
Mar 1, 1995·Pharmacotherapy·A H Burstein
Jan 1, 1991·Epilepsia·A Richens, A W Yuen
Jan 1, 1991·Epilepsia·T BettsA W Yuen
Jan 1, 1992·Epilepsia·M J Brodie
Jan 1, 1993·Epilepsia·L Gram, D Schmidt
Jan 1, 1993·Epilepsia·D SmithM Dewey
Jan 1, 1993·Epilepsia·R E Ramsay
Jan 1, 1994·Epilepsia·A W Yuen
Jan 1, 1994·Epilepsia·A Richens
Jan 1, 1995·Epilepsia·B F Bourgeois
Jan 1, 1995·Epilepsia·J A Messenheimer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.